BioSpace News Archive

Enrollment Continues for Phase 2 study for oral PTH in Osteoporosis; Top-line 3-month Biomarker Data expected in mid 2020

Immuron completes first meeting with FDA on development of IMM-124E as product to specifically prevent Travelers’ Diarrhea (TD)

Leading life sciences consulting firm Clarkston Consulting announces the launch of Clarkston’s Life Sciences Accelerator, a solution that enables the rapid and efficient deployment of the industry-leading SAP S/4HANA platform.

iOmx Therapeutics AG (iOmx), a biopharmaceutical company developing cancer therapeutics based on novel immune checkpoint targets, announced today that its Vice President, Antibody Development, Stefanie Urlinger, PhD, delivered a podium presentation highlighting the discovery of IGSF11

Vor Biopharma, an oncology company pioneering engineered hematopoietic stem cells (eHSCs) for the treatment of cancer, and MaxCyte, Inc., a global cell-based therapies and life sciences company, today announced a clinical and commercial license agreement under which Vor will use MaxCyte’s Flow Electroporation® technology to produce eHSCs and initiate Investigational New Drug (IND)-enabling studies to accelerate its progress towards the clinic

Aruna Bio, Inc. announced that Dr. Mark Sirgo, Chief Executive Officer, and Dr. Steve Stice, Chief Scientific Officer, will be presenting at the 31st Annual Piper Jaffray Healthcare Conference in New York City on Thursday, December 5th at a new time of 9:30 AM Eastern Time.

While most service members have experienced symptoms, only 53 percent have sought professional counseling

Technavio has announced its latest market research report titled global medical specialty bags market 2019-2023

Contraceptive Program Supported by up to $20.5 Million in Grant Funding from the Bill & Melinda Gates Foundation

VBL Therapeutics announced that data on the new investigator-sponsored Phase 2 study of VB-111 in recurrent glioblastoma will be presented by Timothy Cloughesy, M.D., Director and Professor, UCLA Neuro-Oncology Program at the 2019 Society for Neuro-Oncology annual meeting, being held November 20-24, 2019 in Phoenix, Arizona.